Names | |
---|---|
IUPAC name
8-[5-(5,7-Dihydroxy-4-oxo-chromen-2-yl)-2-hydroxy-phenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
|
|
Other names
Didemethyl-ginkgetin
3′,8′′-Biapigenin |
|
Identifiers | |
1617-53-4 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL63354 |
ChemSpider | 4444919 |
PubChem | 5281600 |
|
|
|
|
Properties | |
C30H18O10 | |
Molar mass | 538.46 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
Amentoflavone is a biflavonoid (bis-apigenin coupled at 8 and 3' positions, or 3′,8′′-biapigenin) constituent of a number of plants including Ginkgo biloba, Chamaecyparis obtusa (hinoki), Hypericum perforatum (St. John’s Wort) and Xerophyta plicata.
Amentoflavone can interact with many medications by being a potent inhibitor of CYP3A4 and CYP2C9, which are enzymes responsible for the metabolism of some drugs in the body. It is also an inhibitor of human cathepsin B.
Amentoflavone has a variety of in vitro activities including antimalarial activity, anticancer activity (which may, at least in part, be mediated by its inhibition of fatty acid synthase), and antagonist activity at the κ-opioid receptor (Ke = 490 nM) as well as activity at the allosteric benzodiazepine site of the GABAA receptor as a negative allosteric modulator.